BRIEF published on 03/11/2024 at 13:05, 2 years 6 months ago Kayne Anderson Growth Capital Acquires Majority Stake in Telehealth Leader TeleMed2U Healthcare Technology Investment Kayne Anderson Growth Capital Telehealth TeleMed2U
BRIEF published on 03/11/2024 at 13:05, 2 years 6 months ago Kayne Anderson Growth Capital acquiert une participation majoritaire dans le leader de la télésanté TeleMed2U Investissement Technologie De La Santé Télésanté TeleMed2U Kayne Anderson Capital De Croissance
PRESS RELEASE published on 03/11/2024 at 13:00, 2 years 6 months ago Kayne Anderson Growth Capital Invests in TeleMed2U, a Multi-Specialty Telehealth Platform TeleMed2U announces strategic partnership with Kayne Anderson Growth Capital for enhanced telemedicine services and network expansion Healthcare Technology Strategic Partnership Kayne Anderson Growth Capital TeleMed2U Telemedicine Solutions
Published on 09/11/2026 at 15:25, 52 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 1 hour 17 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 1 hour 47 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 2 hours 19 minutes ago BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 3 hours 17 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 16:00, 17 minutes ago Deutsche Postbank Funding Trust III published semi-annual report
Published on 09/11/2026 at 16:00, 17 minutes ago Form 8.3 - IPConcept (Luxemburg) S.A.: SONNTAG Premium
Published on 09/11/2026 at 15:29, 48 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/11/2026 at 07:00, 9 hours 17 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 9 hours 17 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 9 hours 17 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 20 hours 47 minutes ago Availability of the 2026 Interim Financial Report
